Work

Abstract PS4-08-03: An Exploratory Clinical Study for Neoadjuvant Treatment of HER2-low Expressing, Stage II-III Breast Cancer with Vedolizumab in Combination with Pembrolizumab

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-08-03

Authors: T. Luo, X. Liu, Y. Song, C. Zhuang, P. He, X. Zeng, D. Zheng, X. Yan, X. Zhong, T. Tian, B. Wei, Y. Xie, J. Chen, Q. Lv

Institutions: Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, Xuzhou Medical College

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129730158

Cites:

Cited by:

Related to: